Your browser doesn't support javascript.
loading
Utility of ankyrin 3 as a prognostic marker in androgen-receptor-positive breast cancer.
Kurozumi, Sasagu; Joseph, Chitra; Raafat, Sara; Sonbul, Sultan; Kariri, Yousif; Alsaeed, Sami; Pigera, Marian; Alsaleem, Mansour; Nolan, Christopher C; Johnston, Simon J; Aleskandarany, Mohammed A; Ogden, Angela; Fujii, Takaaki; Shirabe, Ken; Martin, Stewart G; Alshankyty, Ibraheem; Mongan, Nigel P; Ellis, Ian O; Green, Andrew R; Rakha, Emad A.
Afiliação
  • Kurozumi S; Division of Cancer and Stem Cells, Nottingham Breast Cancer Research Centre, School of Medicine, University of Nottingham, Nottingham, UK.
  • Joseph C; Department of General Surgical Science, Gunma University Graduate School of Medicine, Gunma, Japan.
  • Raafat S; Division of Cancer and Stem Cells, Nottingham Breast Cancer Research Centre, School of Medicine, University of Nottingham, Nottingham, UK.
  • Sonbul S; Division of Cancer and Stem Cells, Nottingham Breast Cancer Research Centre, School of Medicine, University of Nottingham, Nottingham, UK.
  • Kariri Y; Department of Pathology, Faculty of Medicine, Mansoura University, Mansoura, Egypt.
  • Alsaeed S; Division of Cancer and Stem Cells, Nottingham Breast Cancer Research Centre, School of Medicine, University of Nottingham, Nottingham, UK.
  • Pigera M; Division of Cancer and Stem Cells, Nottingham Breast Cancer Research Centre, School of Medicine, University of Nottingham, Nottingham, UK.
  • Alsaleem M; Division of Cancer and Stem Cells, Nottingham Breast Cancer Research Centre, School of Medicine, University of Nottingham, Nottingham, UK.
  • Nolan CC; Division of Cancer and Stem Cells, Nottingham Breast Cancer Research Centre, School of Medicine, University of Nottingham, Nottingham, UK.
  • Johnston SJ; Division of Cancer and Stem Cells, Nottingham Breast Cancer Research Centre, School of Medicine, University of Nottingham, Nottingham, UK.
  • Aleskandarany MA; Division of Cancer and Stem Cells, Nottingham Breast Cancer Research Centre, School of Medicine, University of Nottingham, Nottingham, UK.
  • Ogden A; Division of Cancer and Stem Cells, Nottingham Breast Cancer Research Centre, School of Medicine, University of Nottingham, Nottingham, UK.
  • Fujii T; Division of Cancer and Stem Cells, Nottingham Breast Cancer Research Centre, School of Medicine, University of Nottingham, Nottingham, UK.
  • Shirabe K; Faculty of Medicine, Menoufyia University, Shebin El Kom, Egypt.
  • Martin SG; Division of Cancer and Stem Cells, Nottingham Breast Cancer Research Centre, School of Medicine, University of Nottingham, Nottingham, UK.
  • Alshankyty I; Department of General Surgical Science, Gunma University Graduate School of Medicine, Gunma, Japan.
  • Mongan NP; Department of General Surgical Science, Gunma University Graduate School of Medicine, Gunma, Japan.
  • Ellis IO; Division of Cancer and Stem Cells, Nottingham Breast Cancer Research Centre, School of Medicine, University of Nottingham, Nottingham, UK.
  • Green AR; Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Rakha EA; Cancer Biology and Translational Research, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham, UK.
Breast Cancer Res Treat ; 176(1): 63-73, 2019 Jul.
Article em En | MEDLINE | ID: mdl-30941650
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptores Androgênicos / Biomarcadores Tumorais / Anquirinas Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Breast Cancer Res Treat Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptores Androgênicos / Biomarcadores Tumorais / Anquirinas Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Breast Cancer Res Treat Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido